Kaberi Nath

Kaberi Nath is a seasoned professional with a diverse background in biotechnology and research. Currently serving as a Senior C&I Analyst at McKinsey & Company since October 2022, Kaberi previously held positions including C&I Analyst at the same firm and Assay Development Scientist at Achira Labs Pvt. Ltd., where expertise was applied in biosensor-based multiplex immunoassays on a microfluidics platform. Prior experiences also include a role as a Senior Research Associate at Syngene International Limited, focusing on immune-oncology, as well as freelance reviewing at Cactus Communications. Academic qualifications encompass a Master’s degree in Pharmaceutical Biotechnology from the Institute of Chemical Technology and a Bachelor’s degree in Bioengineering and Technology from Gauhati University.